Plain-English translation of NCT07039396 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing NeoThelium FT, a graft made from amniotic membrane, to see if it can help heal diabetic foot ulcers more effectively. You would receive this treatment weekly, along with standard wound care practices like cleaning and dressing changes. The study wants to understand how well this medication works and whether insurance should cover it.
Diabetic foot ulcers can be slow to heal and may lead to serious complications like infection or amputation. Researchers believe that this medication may improve healing by providing the wound with biological support, and this study aims to confirm whether it actually works in real-world patient care.
You likely qualify if…
You likely don't qualify if…
You would visit the medical center weekly for treatment visits where your wound would be cleaned, the amniotic membrane graft applied, and a fresh dressing placed. Between visits, you would wear an offloading device (like a special boot) to take pressure off the ulcer. You would continue attending follow-up appointments according to the original schedule, and the study team would monitor your wound healing progress over time. This is a small study with only 10 participants total.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States
Sponsor
NuScience Medical Biologics, LLC
Collaborators
SygNola, LLC
Enrollment target
~10 participants
Started
August 2025
Primary completion
May 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Angelina Ferguson, DNP
SygNola, LLC
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.